Literature DB >> 2224271

Invasive aspergillosis in immunosuppressed patients: potential hazard of hospital building work.

A G Dewhurst1, M J Cooper, S M Khan, A P Pallett, J R Dathan.   

Abstract

Entities:  

Mesh:

Year:  1990        PMID: 2224271      PMCID: PMC1663914          DOI: 10.1136/bmj.301.6755.802

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  15 in total

1.  Management of infection in the neutropenic patient.

Authors:  R E Marcus; J M Goldman
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-16

2.  Efficacy of infection control measures during a nosocomial outbreak of disseminated aspergillosis associated with hospital construction.

Authors:  S M Opal; A A Asp; P B Cannady; P L Morse; L J Burton; P G Hammer
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

3.  Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia.

Authors:  S L Gerson; G H Talbot; S Hurwitz; B L Strom; E J Lusk; P A Cassileth
Journal:  Ann Intern Med       Date:  1984-03       Impact factor: 25.391

4.  Empirical antifungal therapy in neutropenic patients.

Authors:  J Cohen
Journal:  J Antimicrob Chemother       Date:  1984-05       Impact factor: 5.790

5.  Invasive aspergillosis in acute leukemia: correlation with nose cultures and antibiotic use.

Authors:  J Aisner; J Murillo; S C Schimpff; A C Steere
Journal:  Ann Intern Med       Date:  1979-01       Impact factor: 25.391

Review 6.  Extrinsic risk factors for pneumonia in the patient at high risk of infection.

Authors:  F S Rhame; A J Streifel; J H Kersey; P B McGlave
Journal:  Am J Med       Date:  1984-05-15       Impact factor: 4.965

7.  Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy.

Authors:  T L Gustafson; W Schaffner; G B Lavely; C W Stratton; H K Johnson; R H Hutcheson
Journal:  J Infect Dis       Date:  1983-08       Impact factor: 5.226

8.  Increased recovery of Aspergillus flavus from respiratory specimens during hospital construction.

Authors:  F A Sarubbi; H B Kopf; M B Wilson; M R McGinnis; W A Rutala
Journal:  Am Rev Respir Dis       Date:  1982-01

9.  Nosocomial aspergillosis: a retrospective review of airborne disease secondary to road construction and contaminated air conditioners.

Authors:  J R Lentino; M A Rosenkranz; J A Michaels; V P Kurup; H D Rose; M W Rytel
Journal:  Am J Epidemiol       Date:  1982-09       Impact factor: 4.897

10.  Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response.

Authors:  J Aisner; P H Wiernik; S C Schimpff
Journal:  Ann Intern Med       Date:  1977-05       Impact factor: 25.391

View more
  7 in total

1.  Restriction endonuclease analysis of Aspergillus fumigatus DNA.

Authors:  J P Burnie; A Coke; R C Matthews
Journal:  J Clin Pathol       Date:  1992-04       Impact factor: 3.411

2.  Invasive aspergillosis in immunosuppressed patients.

Authors: 
Journal:  BMJ       Date:  1990-11-03

3.  Cerebral aspergillosis.

Authors:  D Clements; S Leadbeatter; I M Harvey
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

4.  Aspergillosis in immunocompromised paediatric patients: associations with building hygiene, design, and indoor air.

Authors:  K Anderson; G Morris; H Kennedy; J Croall; J Michie; M D Richardson; B Gibson
Journal:  Thorax       Date:  1996-03       Impact factor: 9.139

Review 5.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

6.  Successful treatment of concomitant pulmonary nocardiosis and aspergillosis in an immunocompromised renal patient.

Authors:  R I Holt; J T Kwan; A M Sefton; J Cunningham
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-02       Impact factor: 3.267

Review 7.  Infection control measures to prevent invasive mould diseases in hematopoietic stem cell transplant recipients.

Authors:  Kimberly Partridge-Hinckley; Gale M Liddell; Nikolaos G Almyroudis; Brahm H Segal
Journal:  Mycopathologia       Date:  2009-12       Impact factor: 2.574

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.